Nuwellis, Inc. (NUWE)
NCM · Healthcare · Medical Devices
Closing price as of 2026-07-30 · Source: TEK2day Finance
Key Metrics
About Nuwellis, Inc.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through specialty healthcare distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 1.7M | 2.2M | 2.4M | 2.4M |
| Gross Profit | 958K | 1.4M | 1.7M | 1.7M |
| Operating Income | -2.9M | -2.7M | -2.4M | -4.6M |
| Net Income | -12.6M | 468K | -2.4M | -4.5M |
| Diluted EPS | $-60.97 | $0.56 | $-1.50 | $-2.09 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 8.5M | 8.9M | 8.7M | 8.3M |
| Gross Profit | 4.8M | 5.0M | 5.7M | 5.1M |
| Operating Income | -17.2M | -17.6M | -11.0M | -11.1M |
| Net Income | -14.5M | -20.2M | -11.2M | -17.5M |
| Diluted EPS | $-947.80 | $-16,934.40 | $-353.22 | $-25.39 |